4-Bromo-2-(2,6-dioxopiperidin-3-yl)-5-fluoroisoindoline-1,3-dione
PG-20161-44846
CAS 2851889-86-4MW 355.1
Same subcategory
5-Bromo-2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione
PG-20161-68373
Product information
- Catalog No.
- PG-20161-68373
- Product Name
- 5-Bromo-2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione
- CAS No.
- 2740657-28-5
- Molecular Formula
- C13H8BrFN2O4
- Molecular Weight
- 355.1
- Purity
- Not specified
- Storage
- -20°C
- Shipping
- Ambient Temperature
- Documents
Missing values are marked “Not specified”. Request the technical information you need with your inquiry. For research use only.
Packaging & pricing
| Catalog No. | Packaging | Price (USD) | Stock | Inquiry action |
|---|---|---|---|---|
| PG-20161-68373 | 50 MG | USD 83 | In stock | |
| PG-20161-68373 | 100 MG | USD 147 | In stock | |
| PG-20161-68373 | 250 MG | USD 287 | In stock |
Prices are shown in USD. Final pricing, package availability and delivery are confirmed with your quotation.
General Information
- Product Name
- 5-Bromo-2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione
- CAS No.
- 2740657-28-5
- Synonyms
- Not specified
- Molecular Formula
- C13H8BrFN2O4
- Molecular Weight
- 355.1
- Appearance
- Not specified
- Solubility
- Not specified
- Description
5-Bromo-2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione is a thalidomide analogue offered within the thalidomide-based ligand and PROTAC linker collections. The fluorine and bromine positions provide sites for derivatization by substitution. Its thalidomide scaffold is relevant to PROTAC research involving E3 ligase recruitment and subsequent target-protein degradation.
This reagent-grade compound is intended for laboratory research only. It has the molecular formula C13H8BrFN2O4 and a molecular weight of 355.1, with storage specified at -20°C.